Tumor mutational burden as a marker for radiologic response to immune checkpoint inhibitors
Higher TMB was associated with objective response to ICI, however, TMB was an imperfect biomarker for PFS and OS in our study.
Authors
- Sree Harsha Tirumani
- Brandon Declouette
- Dheeman Futela (ORCID: https://orcid.org/0000-0003-0073-375X)
- Christopher Hoimes (ORCID: https://orcid.org/0000-0001-8980-2410)
- Nikhil H. Ramaiya
- Ezgi Güler (ORCID: https://orcid.org/0000-0002-8028-0350)
Institutions
- Duke University (US)
- University Hospitals of Cleveland (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Current Problems in Diagnostic Radiology
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1067/j.cpradiol.2024.12.010
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28